Loading…
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
57pct
16d open
vs 5,767 other HR bills in the 107th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2006 · year_end · Labor Issues/Antitrust/Workplace
HR 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 52006 S 3678, pandemic and All-Hazards Preparedness Act. S 1873, Biodefense and Pandemic Vaccine and Drug Development Act of 2005 Anti-trust exemption.
Client expense: Not reported · Firm income: $160,000
Government targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2006 · year_end · Labor Issues/Antitrust/Workplace
Antitrust for Biodefense/Pandemic Planning and Response H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act S. 3678: Pandemic and All-Hazards Preparedness Act
Client expense: $2,860,000 · Firm income: Not reported
2006 · year_end · Medical/Disease Research/Clinical Labs
Orphan Drug Research H.R. 5080: Orphan Drug Tax Credit Funding for Pandemic Preparedness H.R. 5647: Labor/HHS/Education Appropriations H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act S. 3678: Pandemic and All-Hazards Preparedness Act Funding for Critical Path at FDA H.R. 5384: Agriculture and Related Agencies Appropriations Stem Cell Research H.R. 810: Stem Cell Research S. 2504: Fetus Farming Prohibition Act R&D Tax Credits H.R. 5115: U.S. Healthcare Technologies Competitiveness Act of 2006 H.R. 4082/S. 189: Biotechnology Future Investment Act of 2005 FDA Funding H.R. 5384 2008 Budget
Client expense: $2,860,000 · Firm income: Not reported
2006 · year_end · Homeland Security
Funding for Pandemic Preparedness H.R. 5647: Labor/HHS/Education Appropriation H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense & Pandemic Biodefense Advanced R&D and Procurement Reform H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Biodefense and Pandemic Regulatory Guidance Vaccine Tracking Information Disclosure S. 3678: Pandemic and All-Hazards Preparedness Act Antitrust Exemptions H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense Information Technology to Improve Situational Awareness S.3678: Pandemic & All-Hazards Preparedness Act
Client expense: $2,860,000 · Firm income: Not reported
2006 · year_end · Health Issues
Generic Biologics (HR 6257, S 4016) The Lower Priced Drugs Act (S 2300, HR 6022) Release of Medicare Claims Database (Medicare Quality Enhancement Act, S 3900) Medicare Implementation issues Office of Generic Drug funding (HR 5384, FY 2007 Agriculture Appropriations) Transparency of Price and Quality Standards Bioshield/Biodefense legislation (S 1873, HR 5533, S 2564, S 3678) Comparative Effectiveness (HR 5647, S 3708, Labor-HHS FY 2007 Appropriations) Health Information Technology (S 1418, HR 4157) Health Savings Accounts (HR 4511, S 3585, HR 5743, HR 6111)
Client expense: $4,000,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Natl Security Council (NSC), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of Thrift Supervision (OTS), Office of the Comptroller of the Currency (OCC), Overseas Private Investment Corp (OPIC), SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2006 · year_end · Health Issues
Biodefense and Pandemic: Hr. 5533, S. 1973 (prev. S. 2564), Biodefense and Pandemic Vaccine and Drug Development Act; HR. 3678, Pandemic and All-Hazards Preparedness Act. Tricare Retail Pharmacy, HR. 5122, S.2767: Department of Defense Authorization. Follow-On Biologics: HR. 6237, Access to Lifesaving Medicines Act. Drug Safety: S. 3807, Enhancing Drug Safety and Innovation Act of 2006. ***, no specific bill, Critical Path.
Client expense: Not reported · Firm income: $160,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2006 · year_end · Disaster Planning/Emergencies
H.R. 5533 & S. 1873 - Biodefense and Pandemic Vaccine and Drug Development Act - provisions relating to Avian flue preparedness; S. 975 - Project BioShield II Act of 2005 - all provisions; S. 3678 - Pandemic and All-Hazards Preparedness Act - all provisions (became P.L. 109 - 417).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Health Issues
Vaccine & immunization programs; product liability; influenza vaccine stockpiles & appropriations & safety: S.2554, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R. 2863, H.R. 5587, H.R. 4245, S. 1821, S. 96, S. 3627, S. 843, H.r. 3970, S. 1826, S. 1437, S. 969, S. 3492, S. 1527, H.R. 3502
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2006 · year_end · Homeland Security
Biodefense Vaccine R&D and acquisition under Project BioShield and the DHHS/CDC Strategic National Stockpile and related authorization and appropriations legislation; S. 1880, S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, H.R. 2863
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2006 · year_end · Health Issues
BioShield, Biodefense vaccine biological R&D, procurement for Strategic National Stockpile, & product liability related oversight, authorizing, & appropriations legislation; DHHS & CDC procurement of anthrax vaccines; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1880, H.R 2863
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office
2006 · year_end · Homeland Security
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues; S. 2564, S. 3678, H.R. 5533, H.R. 5647, S. 3708, S. 1889, H.R. 2863
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office
2006 · year_end · Defense
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues; S. 3678, S. 2564, H.R. 5533, S. 3708, H.R 5647
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office
2006 · year_end · Medical/Disease Research/Clinical Labs
S. 2564 S. 3678 H.R. 5533 Public Health Programs for Infectious & Tropical Disease
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2006 · year_end · Pharmacy
43. H.R. 1539, a bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug 44. S. 338, the Bipartisan Commission on Medicaid Act of 2005 45. H.R. 985, the Bipartisan Commission on Medicaid Act of 2005 46. S. Con.Res.18, Budget FY2006 Appropriations resolution 47. H. Con.Res.95, 18, Budget FY2006 Appropriations resolution 48. S. 1262, the Health Technology to Enhance Quality Act of 2005 49. S.3678, the Pandemic and All-Hazards Preparedness Act 50. S.2564, the Biodefense and Pandemic Vaccine and Drug Development Act of 2006 51. H.R. 5533, the Biodefense and Pandemic Vaccine and Drug Development Act 52. H.R. 5262, Tax Free Savings Act of 2006 53. S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act 54. H.R. 4157, the Health Information Technology Promotion Act of 2006 55. S. 2766, the National Defense Authorization Act for Fiscal Year 2007 56. H.R.5122, the National Defense Authorization Act for Fiscal Year 2007 57. S.2810, the Medicare Late Enrollment Assistance Act of 2006 58. H.R.5399, the Medicare Drug Benefit Enrollment Fairness Act of 2006 59. H.R. 5182, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 60. S. 2563, the Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 61. S. 2664, the Pharmacy Access Improvement (PhAIm) Act of 2006 62. H.R. 4769, the Prescription Drug Elimination Act of 2006 63. S. 2300, the Lower Prices With Increased Competition and Efficient Development of Drugs Act (the Lower Priced Drugs Act) 64. H.R. 5166 – The Independent Pharmacy Protection Act of 2006 65. S. 2181, the Medicare State Reimbursement Act 66. S. 2183, the Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act 67. H.R. 4297, the Tax Relief Extension Reconciliation Act 68. H.R. 5384, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 69. H.R.5441, the Department of Homeland Security Appropriations Act, 2007 70. S. 2020, Tax Relief Act of 2005 71. HR 5122 - FY2007 National Defense Authorization Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 72. HR 5182 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 73. S. 2563 - Pharmacist Access and Recognition in Medicare (PHARM) Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 74. S. 1932 - Deficit Reduction Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 1. H.R. 4241, the Deficit Reduction Act of 2005 2. S. 1932, the Senate Deficit Reduction Act of 2005 3. H.R. 6111, the Tax Relief and Health Care Act of 2006 4. H.R. 5280, the Dextromethorphan Distribution Act of 2006 5. S.3807. the Enhancing Drug Safety and Innovation Act of 2006 6. H.R. 6257, the Access to Life-Saving Medicine Act 7. H.R. 5970, the Estate Tax and Extension of Tax Relief Act of 2006 8. S. 1716, Emergency Health Care Relief Act of 2005 9. H.R. 4297, the Tax Relief Extension Reconciliation Act 10. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 11. S. 544, the Patient Safety and Quality Improvement Act of 2005 12. H.R. 3205, the Patient Safety and Quality Improvement Act of 2005 13. H.R. 1132, the National All Schedules Prescription Electronic Reporting Act of 2005 14. S. 518, the National All Schedules Prescription Electronic Reporting Act of 2005 15. S. 1392, the Federal Trade Commission Reauthorization Act of 2005 16. S. 334, the Pharmaceutical Market Access and Drug Safety Act 17. H.R. 700, the Pharmaceutical Market Access and Drug Safety Act of 2005 18. S. 309, the Pharmaceutical Market Access Act 19. H.R. 328, the Pharmaceutical Market Access Act 20. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 21. H.R. 1808, the Safe Online Drug Act of 2005 22. S. 399, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 23. H.R. 840, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 24. S. 14, the Fair Wage, Competition, and Investment Act of 2005 25. S. 534, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 26. H.R. 5, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 27. H.R. 1669, the Pharmacy Benefit Manager Transparency Act of 2005 28. H.R. 1671, the Community Pharmacy Fairness Act of 2005 29. S. 103, the Combat Meth Act of 2005 30. H.R. 314, the Combat Meth Act of 2005 31. S. 102, the Exile Meth Act 32. H.R. 313, the Exile Meth Act 33. H.R. 3889, Meth Epidemic Elimination Act 34. H.R. 1378, the Ephedrine Alkaloids Regulation Act of 2005 35. H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005 36. H.R. 3617, the Medicare Value-Based Purchasing for Physicians' Services Act of 2005 37. S. 1356, the Medicare Value Purchasing Act of 2005 38. S. 1408, the Identity Theft Protection Act 39. S. 1332, the Personal Data Privacy and Security Act of 2005 40. S. 930, the Food and Drug Administration Safety Act of 2005 41. H.R. 1652, the Access to Legal Pharmaceuticals Act 42. S. 809, the Access to Legal Pharmaceuticals Act See addendum
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, White House Office
2006 · year_end · Health Issues
H.R. 1626, the Medicare Prescription Drug Improvement Act Issues pertaining to the prevention of misuse of products containing DMX, including the Dextromethorphan Distribution Act Issues relating to the distribution practices of contact lens manufacturers, including H.R. 1800 and S. 2480 Issues relating to H.R. 5533, the Biodefense and Pandemic Vaccine Drug Development Act Issues regarding the effective date of elements of S. 103, the Combat Meth bill Issues pertaining to the treatment of malaria Issues pertaining to the importation of prescription drugs, including: S. 334, the Pharmaceutical Market Access and Drug Safety Act S. 184, the Safe Import Act S. 109 the Pharmaceutical Market Access Act
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Defense
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to the provisions of S 2564 and S 3678 to address procurement concerns.
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2006 · year_end · Defense
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to provisions of S 2564 and S 3678 to address procurement concerns.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2006 · mid_year · Pharmacy
1. H.R. 4241, House Deficit Reduction Act of 2005 2. S. 1932, Senate Deficit Reduction Act of 2005 3. H.R. 3199, USA Patriot Act Reauthorization 4. S. 1716, Emergency Health Care Relief Act of 2005 5. H.R. 4297, the Tax Relief Extension Reconciliation Act 6. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 7. S. 544, the Patient Safety and Quality Improvement Act of 2005 8. H.R. 3205, the Patient Safety and Quality Improvement Act of 2005 9. H.R. 1132, the National All Schedules Prescription Electronic Reporting Act of 2005 10. S. 518, the National All Schedules Prescription Electronic Reporting Act of 2005 11. S. 1392, the Federal Trade Commission Reauthorization Act of 2005 12. S. 334, the Pharmaceutical Market Access and Drug Safety Act 13. H.R. 700, the Pharmaceutical Market Access and Drug Safety Act of 2005 14. S. 309, the Pharmaceutical Market Access Act 15. H.R. 328, the Pharmaceutical Market Access Act 16. S.3, the Protecting America in the War on Terror Act of 2005 17. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 18. H.R. 1808, the Safe Online Drug Act of 2005 19. S. 399, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 20. H.R. 840, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 21. S. 14, the Fair Wage, Competition, and Investment Act of 2005 22. S. 534, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 23. H.R. 5, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 24. H.R. 1669, the Pharmacy Benefit Manager Transparency Act of 2005 25. H.R. 1671, the Community Pharmacy Fairness Act of 2005 26. S. 103, the Combat Meth Act of 2005 27. H.R. 314, the Combat Meth Act of 2005 28. S. 102, the Exile Meth Act 29. H.R. 313, the Exile Meth Act 30. H.R. 3889, Meth Epidemic Elimination Act 31. H.R. 1446, the Methamphetamine Abuse Prevention Act of 2005 32. H.R. 1055, the Comprehensive Methamphetamine Response Act 33. H.R. 1056, the Methamphetamine Precursor Control Act of 2005 34. H.R. 1378, the Ephedrine Alkaloids Regulation Act of 2005 35. H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005 36. H.R. 3617, the Medicare Value-Based Purchasing for Physicians' Services Act of 2005 37. S. 1356, the Medicare Value Purchasing Act of 2005 38. S. 1408, the Identity Theft Protection Act 39. S. 1332, the Personal Data Privacy and Security Act of 2005 40. S. 930, the Food and Drug Administration Safety Act of 2005 41. H.R. 1652, the Access to Legal Pharmaceuticals Act 42. S. 809, the Access to Legal Pharmaceuticals Act 43. H.R. 1539, a bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug 44. S. 338, the Bipartisan Commission on Medicaid Act of 2005 45. H.R. 985, the Bipartisan Commission on Medicaid Act of 2005 46. S. Con.Res.18, Budget FY2006 Appropriations resolution 47. H. Con.Res.95, 18, Budget FY2006 Appropriations resolution 48. S. 1262, the Health Technology to Enhance Quality Act of 2005 49. S.3678, the Pandemic and All-Hazards Preparedness Act 50. S.2564, the Biodefense and Pandemic Vaccine and Drug Development Act of 2006 51. H.R. 5533, the Biodefense and Pandemic Vaccine and Drug Development Act 52. H.R. 5262, Tax Free Savings Act of 2006 53. S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act 54. H.R. 4157, the Health Information Technology Promotion Act of 2005 55. S. 2766, the National Defense Authorization Act for Fiscal Year 2007 56. S.2810, the Medicare Late Enrollment Assistance Act of 2006 57. H.R.5399, the Medicare Drug Benefit Enrollment Fairness Act of 2006 58. H.R. 5182, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 59. S. 2563, the Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 60. S. 2664, the Pharmacy Access Improvement (PhAIm) Act of 2006 61. H.R. 4769, the Prescription Drug Elimination Act of 2006 62. S. 2300, the Lower Prices With Increased Competition and Efficient Development of Drugs Act (the Lower Priced Drugs Act) 63. H.R. 5166 – The Independent Pharmacy Protection Act of 2006 64. S. 2181, the Medicare State Reimbursement Act 65. S. 2183, the Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act 66. H.R. 4297, the Tax Relief Extension Reconciliation Act 67. H.R. 5384, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 68. H.R.5441, the Department of Homeland Security Appropriations Act, 2007 69. S. 2020, Tax Relief Act of 2005
Client expense: $460,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE, White House Office
2005 · year_end · Medical/Disease Research/Clinical Labs
Fiscal Year 2007 Labor-HHS Appropriations (H.R. 5647) Pandemic and All-Hazards Preparedness Act (S. 3678) Biodefense and Pandemic Vaccine and Drug Development Act (S. 2564, H.R. 5533)
Client expense: $700,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2005 · year_end · Science/Technology
Pandemic and All-Hazards Preparedness Act (S. 3678) Biodefense and Pandemic Vaccine and Drug Development Act (S. 2564, H.R. 5533)
Client expense: $700,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2005 · year_end · Government Issues
Pandemic and All-Hazards Preparedness Act (S. 3678) Biodefense and Pandemic Vaccine and Drug Development Act (S. 2564, H.R. 5533)
Client expense: $700,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE